ID

25033

Descripción

Study ID: 101468/166 Clinical Study ID: SKF-101468/166 Study Title: A Phase II, randomised, double-blind, active-controlled, dose-escalation study to determine the maximum well-tolerated starting dose of a new formulation of ropinirole in Parkinson's Disease patients not receiving other dopaminergic therapies Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Parkinson Disease

Palabras clave

Versiones (2)
  1. 24/8/17 24/8/17 -
  2. 4/9/17 4/9/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

24 de agosto de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

end of study determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166

Inglés

end of study determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166

1 formularios  
Administrative Data
Descripción

Administrative Data

Alias
UMLS CUI-1
C1320722
Patient Initials
Descripción

patient's initials

Tipo de datos

text

Alias
UMLS CUI [1]
C2986440
Patient No.
Descripción

patient number

Tipo de datos

integer

Alias
UMLS CUI [1]
C1830427
Date of Visit
Descripción

date of visit

Tipo de datos

date

Alias
UMLS CUI [1]
C1320303
COMPLETION OF TREATMENT PHASE
Descripción

COMPLETION OF TREATMENT PHASE

Alias
UMLS CUI-1
C0580352
Date of termination
Descripción

date of study termination

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0008972
UMLS CUI [1,3]
C0013135
Did the patient remain on study drug through Day 7?
Descripción

patient's study participation status

Tipo de datos

integer

Did the patient remain on study drug through Day 7?
Descripción

If "NO, discontinued study drug prematurely"; tick the one most significant reason below

Tipo de datos

integer

COMPLETION THROUGH DAY 14
Descripción

COMPLETION THROUGH DAY 14

Alias
UMLS CUI-1
C2348568
Did the patient complete study visits/prodcedures through Day 14?
Descripción

patient's study participation status

Tipo de datos

integer

Did the patient complete study visits/prodcedures through Day 14?
Descripción

If "NO, check the one most significant reason below", choose a reason below.

Tipo de datos

integer

Date of last contact
Descripción

If "Lost to follow-up" above, record the date.

Tipo de datos

date

Alias
UMLS CUI [1]
C0805839
PATIENT DEATH
Descripción

PATIENT DEATH

Alias
UMLS CUI-1
C1306577
Date of death
Descripción

date of death

Tipo de datos

date

Alias
UMLS CUI [1]
C1148348
Was an autopsy performed?
Descripción

If YES, attach a copy of the autopsy report.

Tipo de datos

integer

Alias
UMLS CUI [1]
C0004398
Primary cause of death
Descripción

primary cause of death

Tipo de datos

text

Alias
UMLS CUI [1]
C0007465
Underlying cause(s) of death
Descripción

underlying causes of death

Tipo de datos

text

Alias
UMLS CUI [1]
C0007465
Was death related to study drug?
Descripción

death related to study drug

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0011065
UMLS CUI [1,2]
C0304229
INVESTIGATOR'S SIGNATURE
Descripción

INVESTIGATOR'S SIGNATURE

Alias
UMLS CUI-1
C2346576
Signature
Descripción

I have assumed reponsibility for completeness and accuracy of all data recorded on the case report forms.

Tipo de datos

text

Date
Descripción

I have assumed reponsibility for completeness and accuracy of all data recorded on the case report forms.

Tipo de datos

date

Alias
UMLS CUI [1]
C0807937
Volver a la parte superior de la página

Similar models

end of study determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
patient's initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
patient number
Item
Patient No.
integer
C1830427 (UMLS CUI [1])
date of visit
Item
Date of Visit
date
C1320303 (UMLS CUI [1])
Item Group
COMPLETION OF TREATMENT PHASE
C0580352 (UMLS CUI-1)
date of study termination
Item
Date of termination
date
C0011008 (UMLS CUI [1,1])
C0008972 (UMLS CUI [1,2])
C0013135 (UMLS CUI [1,3])
Item
Did the patient remain on study drug through Day 7?
integer
patient's study participation status
Code List
Did the patient remain on study drug through Day 7?
CL Item
YES (1)
CL Item
NO, discontinued study drug prematurely (2)
Item
Did the patient remain on study drug through Day 7?
integer
patient's study participation status
Code List
Did the patient remain on study drug through Day 7?
CL Item
Adverse event, specify AE (Adverse event must be recorded on the Adverse Events CRF.) (1)
CL Item
Patientrequest (unrelated to AE), specify  (2)
CL Item
Non-compliance(unrelatedto an AE), specify (3)
CL Item
Investigatorjudgement, specify  (4)
CL Item
Termination of patient dosing by sponsor (5)
CL Item
Protocolviolation, specify  (6)
CL Item
Death, complete the Patient Death CRF (7)
CL Item
Other, specify (8)
Item Group
COMPLETION THROUGH DAY 14
C2348568 (UMLS CUI-1)
Item
Did the patient complete study visits/prodcedures through Day 14?
integer
patient's study participation status
Code List
Did the patient complete study visits/prodcedures through Day 14?
CL Item
YES (1)
CL Item
NO, check the one most significant reason below (2)
Item
Did the patient complete study visits/prodcedures through Day 14?
integer
patient's study participation status
Code List
Did the patient complete study visits/prodcedures through Day 14?
CL Item
Death, complete the Patient Death CRF  (1)
CL Item
Lost to follow-up  (2)
CL Item
Other, specify (3)
date of last contact
Item
Date of last contact
date
C0805839 (UMLS CUI [1])
Item Group
PATIENT DEATH
C1306577 (UMLS CUI-1)
date of death
Item
Date of death
date
C1148348 (UMLS CUI [1])
Item
Was an autopsy performed?
integer
C0004398 (UMLS CUI [1])
autopsy
Code List
Was an autopsy performed?
CL Item
YES (1)
CL Item
NO (2)
primary cause of death
Item
Primary cause of death
text
C0007465 (UMLS CUI [1])
underlying causes of death
Item
Underlying cause(s) of death
text
C0007465 (UMLS CUI [1])
Item
Was death related to study drug?
integer
C0011065 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
death related to study drug
Code List
Was death related to study drug?
CL Item
YES (1)
CL Item
NO (2)
Item Group
INVESTIGATOR'S SIGNATURE
C2346576 (UMLS CUI-1)
investigator's signature
Item
Signature
text
signature date
Item
Date
date
C0807937 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial